Market Closed -
Other stock markets
|
After market 02:26:00 pm | |||
140.5 EUR | -1.23% | 141.2 | +0.48% |
Apr. 26 | Transcript : IMCD N.V., Q1 2024 Earnings Call, Apr 26, 2024 | |
Apr. 24 | IMCD's Spanish Unit to Buy Cobapharma | MT |
Sales 2024 * | 4.77B 5.1B | Sales 2025 * | 5.07B 5.42B | Capitalization | 8.1B 8.66B |
---|---|---|---|---|---|
Net income 2024 * | 297M 318M | Net income 2025 * | 330M 353M | EV / Sales 2024 * | 1.94 x |
Net Debt 2024 * | 1.17B 1.26B | Net Debt 2025 * | 979M 1.05B | EV / Sales 2025 * | 1.79 x |
P/E ratio 2024 * |
27.8
x | P/E ratio 2025 * |
25.1
x | Employees | - |
Yield 2024 * |
1.57% | Yield 2025 * |
1.67% | Free-Float | 98.13% |
Latest transcript on IMCD N.V.
1 day | -1.44% | ||
1 week | -9.17% | ||
Current month | -14.17% | ||
1 month | -14.49% | ||
3 months | -0.14% | ||
6 months | +25.18% | ||
Current year | -11.01% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 20-06-29 | |
Hans Kooijmans
DFI | Director of Finance/CFO | 63 | 11-02-28 |
Marcus Jordan
COO | Chief Operating Officer | 50 | 97-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 18-05-08 | |
Amy Motto
BRD | Director/Board Member | 52 | 20-06-29 |
Willem Eelman
BRD | Director/Board Member | 60 | 22-05-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.06% | 303 M€ | +12.00% | ||
0.37% | 18 M€ | +3.01% | - | |
0.21% | 2 M€ | +8.84% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 140.5 | -1.23% | 113 936 |
24-04-30 | 142.2 | -1.28% | 94,262 |
24-04-29 | 144.1 | +1.69% | 174,488 |
24-04-26 | 141.7 | -4.90% | 511,882 |
24-04-25 | 149 | -1.65% | 161,220 |
Real-time Euronext Amsterdam, May 02, 2024 at 04:50 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.01% | 8.65B | |
+34.89% | 1.07B | |
+10.50% | 177M | |
+54.79% | 161M | |
+7.32% | 115M | |
+3.54% | 114M | |
+9.12% | 87.17M |
- Stock Market
- Equities
- IMCD Stock